Current status of PET/CT in the diagnosis and follow up of lymphomas

Detalhes bibliográficos
Autor(a) principal: Buchpiguel,Carlos Alberto
Data de Publicação: 2011
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Revista brasileira de hematologia e hemoterapia (Online)
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-84842011000200013
Resumo: Lymphomas are a heterogeneous group of malignancies that have a distinct biological behavior according to the subtype and degree of differentiation. Adequate staging, which has a direct impact on prognosis, is essential to properly plan therapy. Structural cross-sectional imaging, such as computed tomography, has been the standard imaging tool to stage and monitor patients with lymphoma. However, molecular imaging such as positron emission tomography has shown complementary diagnostic and prognostic values. This review discusses the current value of positron emission tomography imaging using 2-[fluorine-18]fluoro-2-deoxy-d-glucose in staging, restaging, monitoring and detecting relapse in Hodgkin's and non-Hodgkin lymphoma.
id ABHHTC-1_664c0ad0e52d29dab84654cced23d10c
oai_identifier_str oai:scielo:S1516-84842011000200013
network_acronym_str ABHHTC-1
network_name_str Revista brasileira de hematologia e hemoterapia (Online)
repository_id_str
spelling Current status of PET/CT in the diagnosis and follow up of lymphomasLymph Nodes/radionuclide imagingLymphoma/radionuclide imagingPositron-emission tomographyFluorodeoxyglucose F18/diagnostic useLymphoma, Hodgkin's diseaseLymphoma, non-HodgkinLymphomas are a heterogeneous group of malignancies that have a distinct biological behavior according to the subtype and degree of differentiation. Adequate staging, which has a direct impact on prognosis, is essential to properly plan therapy. Structural cross-sectional imaging, such as computed tomography, has been the standard imaging tool to stage and monitor patients with lymphoma. However, molecular imaging such as positron emission tomography has shown complementary diagnostic and prognostic values. This review discusses the current value of positron emission tomography imaging using 2-[fluorine-18]fluoro-2-deoxy-d-glucose in staging, restaging, monitoring and detecting relapse in Hodgkin's and non-Hodgkin lymphoma.Associação Brasileira de Hematologia e Hemoterapia e Terapia Celular2011-01-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-84842011000200013Revista Brasileira de Hematologia e Hemoterapia v.33 n.2 2011reponame:Revista brasileira de hematologia e hemoterapia (Online)instname:Associação Brasileira de Hematologia e Hemoterapia e Terapia Celular (ABHHTC)instacron:ABHHTC10.5581/1516-8484.20110035info:eu-repo/semantics/openAccessBuchpiguel,Carlos Albertoeng2011-06-13T00:00:00Zoai:scielo:S1516-84842011000200013Revistahttp://www.rbhh.org/pt/archivo/https://old.scielo.br/oai/scielo-oai.phpsbhh@terra.com.br||secretaria@rbhh.org1806-08701516-8484opendoar:2011-06-13T00:00Revista brasileira de hematologia e hemoterapia (Online) - Associação Brasileira de Hematologia e Hemoterapia e Terapia Celular (ABHHTC)false
dc.title.none.fl_str_mv Current status of PET/CT in the diagnosis and follow up of lymphomas
title Current status of PET/CT in the diagnosis and follow up of lymphomas
spellingShingle Current status of PET/CT in the diagnosis and follow up of lymphomas
Buchpiguel,Carlos Alberto
Lymph Nodes/radionuclide imaging
Lymphoma/radionuclide imaging
Positron-emission tomography
Fluorodeoxyglucose F18/diagnostic use
Lymphoma, Hodgkin's disease
Lymphoma, non-Hodgkin
title_short Current status of PET/CT in the diagnosis and follow up of lymphomas
title_full Current status of PET/CT in the diagnosis and follow up of lymphomas
title_fullStr Current status of PET/CT in the diagnosis and follow up of lymphomas
title_full_unstemmed Current status of PET/CT in the diagnosis and follow up of lymphomas
title_sort Current status of PET/CT in the diagnosis and follow up of lymphomas
author Buchpiguel,Carlos Alberto
author_facet Buchpiguel,Carlos Alberto
author_role author
dc.contributor.author.fl_str_mv Buchpiguel,Carlos Alberto
dc.subject.por.fl_str_mv Lymph Nodes/radionuclide imaging
Lymphoma/radionuclide imaging
Positron-emission tomography
Fluorodeoxyglucose F18/diagnostic use
Lymphoma, Hodgkin's disease
Lymphoma, non-Hodgkin
topic Lymph Nodes/radionuclide imaging
Lymphoma/radionuclide imaging
Positron-emission tomography
Fluorodeoxyglucose F18/diagnostic use
Lymphoma, Hodgkin's disease
Lymphoma, non-Hodgkin
description Lymphomas are a heterogeneous group of malignancies that have a distinct biological behavior according to the subtype and degree of differentiation. Adequate staging, which has a direct impact on prognosis, is essential to properly plan therapy. Structural cross-sectional imaging, such as computed tomography, has been the standard imaging tool to stage and monitor patients with lymphoma. However, molecular imaging such as positron emission tomography has shown complementary diagnostic and prognostic values. This review discusses the current value of positron emission tomography imaging using 2-[fluorine-18]fluoro-2-deoxy-d-glucose in staging, restaging, monitoring and detecting relapse in Hodgkin's and non-Hodgkin lymphoma.
publishDate 2011
dc.date.none.fl_str_mv 2011-01-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-84842011000200013
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-84842011000200013
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.5581/1516-8484.20110035
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Associação Brasileira de Hematologia e Hemoterapia e Terapia Celular
publisher.none.fl_str_mv Associação Brasileira de Hematologia e Hemoterapia e Terapia Celular
dc.source.none.fl_str_mv Revista Brasileira de Hematologia e Hemoterapia v.33 n.2 2011
reponame:Revista brasileira de hematologia e hemoterapia (Online)
instname:Associação Brasileira de Hematologia e Hemoterapia e Terapia Celular (ABHHTC)
instacron:ABHHTC
instname_str Associação Brasileira de Hematologia e Hemoterapia e Terapia Celular (ABHHTC)
instacron_str ABHHTC
institution ABHHTC
reponame_str Revista brasileira de hematologia e hemoterapia (Online)
collection Revista brasileira de hematologia e hemoterapia (Online)
repository.name.fl_str_mv Revista brasileira de hematologia e hemoterapia (Online) - Associação Brasileira de Hematologia e Hemoterapia e Terapia Celular (ABHHTC)
repository.mail.fl_str_mv sbhh@terra.com.br||secretaria@rbhh.org
_version_ 1754213111193141248

Registros relacionados